The Role of p66Shc in Diabetes: A Comprehensive Review from Bench to Bedside

J Diabetes Res. 2022 Nov 24:2022:7703520. doi: 10.1155/2022/7703520. eCollection 2022.

Abstract

It is well-documented that diabetes is an inflammatory and oxidative disease, with an escalating global burden. Still, there is no definite treatment for diabetes or even prevention of its harmful complications. Therefore, understanding the molecular pathways associated with diabetes might help in finding a solution. p66Shc is a member of Shc family proteins, and it is considered as an oxidative stress sensor and regulator in cells. There are inconsistent data about the role of p66Shc in inducing diabetes, but accumulating evidence supports its role in the pathogenesis of diabetes-related complications, including macro and microangiopathies. There is growing hope that by understanding and targeting molecular pathways involved in this network, prevention of diabetes or its complications would be achievable. This review provides an overview about the role of p66Shc in the development of diabetes and its complications.

Publication types

  • Review

MeSH terms

  • Diabetes Mellitus* / therapy
  • Humans
  • Oxidative Stress
  • Src Homology 2 Domain-Containing, Transforming Protein 1 / genetics

Substances

  • SHC1 protein, human
  • Src Homology 2 Domain-Containing, Transforming Protein 1